Pale Fire Capital SE’s Adverum Biotechnologies ADVM Stock Holding History

Pale Fire Capital SE’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-363,282	Closed	-$1.65M	–	61
2025 Q3	$1.65M	Buy	363,282 +4,558	+1%	+$13.4K	0.18%	25
2025 Q2	$771K	Sell	358,724 -9,543	-3%	-$26.7K	0.08%	33
2025 Q1	$1.61M	Buy	368,267 +53,113	+17%	+$239K	0.19%	24
2024 Q4	$1.47M	Buy	315,154 +6,783	+2%	+$45.7K	0.33%	17
2024 Q3	$2.16M	Buy	+308,371	New	+$2.24M	0.34%	19

Pale Fire Capital SE's ADVM Position: Q4 2025 in Review

Pale Fire Capital SE sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 363,282 shares — an estimated $1.65M sold.

Pale Fire Capital SE first reported a position in ADVM in Q3 2024 and held it in 5 quarters. The position peaked at $2.16M in Q3 2024. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.

Pale Fire Capital SE reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
Pale Fire Capital SE sold 363,282 Adverum Biotechnologies shares in Q4 2025, an estimated $1.65M.
Pale Fire Capital SE first reported a position in Adverum Biotechnologies in Q3 2024 and held it in 5 quarters.
Pale Fire Capital SE's Adverum Biotechnologies position peaked at $2.16M in Q3 2024.
0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.

Based on Pale Fire Capital SE's 13F filing for Q4 2025, filed 13 Feb 2026.